RSS feed source: National Institute of Health

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

National Cancer Institute (NCI)

Funding Opportunity Title

NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)

Activity Code

K01 Research Scientist Development Award – Research & Training

Announcement Type

Related Notices

See Notices of Special Interest associated with this funding opportunity

April 4, 2024 – Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025. See Notice NOT-OD-24-084August 31, 2022– Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.August 5, 2022– Implementation Details

Click this link to continue reading the article on the source website.

RSS feed source: National Institute of Health

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

National Institute on Drug Abuse (NIDA)

Funding Opportunity Title

NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

Activity Code

R25 Education Projects

Announcement Type

Related Notices

See Notices of Special Interest associated with this funding opportunity

April 4, 2024 – Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025. See Notice NOT-OD-24-084.August 31, 2022– Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.August 5, 2022– Implementation Details for the NIH Data Management

Click this link to continue reading the article on the source website.

RSS feed source: National Institute of Health

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

National Cancer Institute (NCI)

Funding Opportunity Title

Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)

Activity Code

UG3/UH3 Exploratory/Developmental Phased Award Cooperative Agreement

Announcement Type

Related Notices

See Notices of Special Interest associated with this funding opportunity

April 4, 2024 – Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025. See Notice NOT-OD-24-084.August 31, 2022– Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.August 5, 2022– Implementation Details for the NIH Data Management and Sharing

Click this link to continue reading the article on the source website.

RSS feed source: National Institute of Health

Notice of Change to Budget Information for New Investigators in PAR-22-180 “Maximizing Investigators’ Research Award (R35 – Clinical Trial Optional)”

The purpose of this Notice is to update information in PAR-22-180 “Maximizing Investigators’ Research Award (MIRA) (R35 – Clinical Trial Optional)” regarding the budget for New Investigators. This Notice applies to applications submitted to the January 16, 2025 due date and beyond. 

Part 2. Section I. Funding Opportunity DescriptionOverview of the MIRA

Resolving Overlap with Other NIGMS Research Grants During the Award Process

The NOFO currently reads:

Well-funded grantees (having more than $400,000 in direct costs from NIGMS research grants) applying for new MIRAs will generally receive budgets about 12% lower than their previous average NIGMS research funding levels (as determined by NIGMS staff). MIRA budgets for New Investigators will generally be $250,000 in annual direct costs. Note that the Institute

Click this link to continue reading the article on the source website.